The Choice Is Reperfusion Therapy
نویسندگان
چکیده
منابع مشابه
Is Patient Choice the Future of Health Care Systems?
Patient and user choice are at the forefront of the debate on the future direction of health and public services provision in many industrialized countries in Europe and elsewhere. It is used both, as a means to achieve desired policy goals in public health care systems such as greater efficiency and improved quality of care, and as a good with its own intrinsic value. However, the evidence sug...
متن کاملPatient Choice Has Become the Standard Practice in Healthcare Provision: It is Time to Extend its Meaning; Comment on “Is Patient Choice the Future of Health Care Systems?”
The key argument of this commentary is that patient choice has a broader meaning than suggested by consumerist choice models. In increasingly marketized health care systems with diversified and knowledge-based service arrangements, patients are continuously obliged to choose insurers, physicians or hospitals and treatments—whether they like it or not. However, health care users refer to a wide ...
متن کاملEating Behaviour: Is It Always a Conscious Choice?
in the past 40 years there has been drastic increase in the prevalence of obesity worldwide (1). This rapid increase in the prevalence of obesity is not a matter of physiologic or metabolic alteration within people. Thousands of scientific papers are published each year indicating that pharmaceutical companies are working to find possible money making antiobesity agents. Increasing in the preva...
متن کاملis vancomycine still a choice for chronic osteomyelitis empirical therapy in iran?
background pyogenic bacteria and especially staphylococcus aurous (s. aurous) are the most common cause of chronic osteomyelitis. not only treatment protocol of chronic osteomyelitis occasionally is amiss but also this malady responds to treatment difficultly. objectives this study investigates antibiotic resistance pattern of s. aurous isolated from iranian patients who suffer from chronic ost...
متن کاملIs adalimumab protective in ischemia-reperfusion injury in lung?
Objective(s): Increasing cytokines and reactive oxygen species (ROS) during ischemia reperfusion (I-R) leads to the lung damage. Adalimumab (Ada) is a potent tumor necrosis factor-alpha (TNF-α) inhibitor agent. We aimed to evaluate whether Ada would prevent the lung tissue from damage development over the I-R process. Materials and Methods:Twenty seven Wistar albino male rats were divided into...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JACC: Cardiovascular Interventions
سال: 2016
ISSN: 1936-8798
DOI: 10.1016/j.jcin.2016.08.004